Endonovo Therapeutics Inc (ENDV)

[Doyle McBoyle1]

Did anyone else read the going concern on the 10q? Says “...which raises substantial doubt about our ability to continue as a going concern”. “To reduce the risk of not being able to continue..., management is commercializing it’s FDA cleared products and has implemented a business strategy”. What I got from this quarter report is if sofpulse sales aren’t up to par then basically endv is gonna be done... so everyone cross your fingers and keep being excited about a run that we’re not sure is going to hold, I think this is the point where everyone should start to think that if this run get s you to the break even point it might be best to take it cause right now it’s up to sofpulse sales to keep this thing going